These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Monoclonal immunoglobulin deposition disease: light chain and light and heavy chain deposition diseases and their relation to light chain amyloidosis. Clinical features, immunopathology, and molecular analysis. Buxbaum JN; Chuba JV; Hellman GC; Solomon A; Gallo GR Ann Intern Med; 1990 Mar; 112(6):455-64. PubMed ID: 2106817 [TBL] [Abstract][Full Text] [Related]
4. Clinicopathological features and prognosis in immunoglobulin light and heavy chain deposition disease. Masai R; Wakui H; Togashi M; Maki N; Ohtani H; Komatsuda A; Sawada K Clin Nephrol; 2009 Jan; 71(1):9-20. PubMed ID: 19203545 [TBL] [Abstract][Full Text] [Related]
5. Abnormal immunoglobulin synthesis in monoclonal immunoglobulin light chain and light and heavy chain deposition disease. Buxbaum JN Amyloid; 2001 Jun; 8(2):84-93. PubMed ID: 11409038 [TBL] [Abstract][Full Text] [Related]
6. Clinicopathological Characteristics of Light and Heavy Chain Deposition Disease: A Case Series. Wang Y; Chen D; Hu R; Zhang Y; Liang D; Xu F; Liu F; Zhu X; Lin Y; Yang X; Liu X; Xing G; Liang S; Zeng C Am J Kidney Dis; 2024 Oct; 84(4):447-456.e1. PubMed ID: 38750878 [TBL] [Abstract][Full Text] [Related]
7. Unravelling the immunopathological mechanisms of heavy chain deposition disease with implications for clinical management. Bridoux F; Javaugue V; Bender S; Leroy F; Aucouturier P; Debiais-Delpech C; Goujon JM; Quellard N; Bonaud A; Clavel M; Trouillas P; Di Meo F; Gombert JM; Fermand JP; Jaccard A; Cogné M; Touchard G; Sirac C Kidney Int; 2017 Feb; 91(2):423-434. PubMed ID: 27773425 [TBL] [Abstract][Full Text] [Related]
8. Renal manifestations of plasma cell dyscrasias: an appraisal from the patients' bedside to the research laboratory. Herrera GA Ann Diagn Pathol; 2000 Jun; 4(3):174-200. PubMed ID: 10919389 [TBL] [Abstract][Full Text] [Related]
9. Mechanisms of disease: monoclonal immunoglobulin deposition. Amyloidosis, light chain deposition disease, and light and heavy chain deposition disease. Buxbaum J Hematol Oncol Clin North Am; 1992 Apr; 6(2):323-46. PubMed ID: 1582976 [TBL] [Abstract][Full Text] [Related]
10. Monoclonal gammopathy presenting as recurrent nephrotic syndrome: therapeutic implications. Krishnan SG; Valderrama E; Wagner JD; Mattana J; Shah HH; Appel G; Singhal PC Am J Med Sci; 2007 May; 333(5):313-6. PubMed ID: 17505177 [TBL] [Abstract][Full Text] [Related]
11. The clinicopathologic characteristics of kidney diseases related to monotypic IgA deposits. Vignon M; Cohen C; Faguer S; Noel LH; Guilbeau C; Rabant M; Higgins S; Hummel A; Hertig A; Francois H; Lequintrec M; Vilaine E; Knebelmann B; Pourrat J; Chauveau D; Goujon JM; Javaugue V; Touchard G; El Karoui K; Bridoux F Kidney Int; 2017 Mar; 91(3):720-728. PubMed ID: 28069266 [TBL] [Abstract][Full Text] [Related]
12. Light and heavy chain deposition disease with focal amyloid deposition diagnosed with mass spectrometry: a case report. Shimamoto Y; Takahashi N; Katoh N; Matsui Y; Mochizuki Y; Ito M; Yazaki M; Kametani F; Kasuno K; Sekijima Y; Naiki H; Iwano M BMC Nephrol; 2023 Jun; 24(1):187. PubMed ID: 37365566 [TBL] [Abstract][Full Text] [Related]
13. Crescentic nodular glomerulosclerosis secondary to truncated immunoglobulin alpha heavy chain deposition. Cheng IK; Ho SK; Chan DT; Ng WK; Chan KW Am J Kidney Dis; 1996 Aug; 28(2):283-8. PubMed ID: 8768927 [TBL] [Abstract][Full Text] [Related]